ProCE Banner Activity

GU Malignancies at the 2016 Clinical Oncology Meeting: In Anticipation of Practice-Changing Data

Conference Coverage
Clinical Thought
Here are my thoughts on the abstracts from ASCO 2016 that have the most potential to change clinical practice.

Released: May 31, 2016

Expiration: May 30, 2017

No longer available for credit.

Share

Faculty

Brian I. Rini

Brian I. Rini, MD

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals

Faculty Disclosure

Primary Author

Brian I. Rini, MD

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio

Brian Rini, MD, FACP, has disclosed that he has received consulting fees from Novartis and Pfizer and he has received research support from Acceleron, Bristol-Myers Squibb, Immatics, Peloton, and Pfizer.